Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure

Academic Article

Abstract

  • © 2018 American Heart Association, Inc. On March 1 and 2, 2018, the National Institutes of Health 2018 Progenitor Cell Translational Consortium, Cardiovascular Bioengineering Symposium, was held at the University of Alabama at Birmingham. Convergence of life sciences and engineering to advance the understanding and treatment of heart failure was the theme of the meeting. Over 150 attendees were present, and >40 scientists presented their latest work on engineering human functional myocardium for disease modeling, drug development, and heart failure research. The scientists, engineers, and physicians in the field of cardiovascular sciences met and discussed the most recent advances in their work and proposed future strategies for overcoming the major roadblocks of cardiovascular bioengineering and therapy. Particular emphasis was given for manipulation and using of stem/progenitor cells, biomaterials, and methods to provide molecular, chemical, and mechanical cues to cells to influence their identity and fate in vitro and in vivo. Collectively, these works are profoundly impacting and progressing toward deciphering the mechanisms and developing novel treatments for left ventricular dysfunction of failing hearts. Here, we present some important perspectives that emerged from this meeting.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Berry JL; Zhu W; Tang YL; Krishnamurthy P; Ge Y; Cooke JP; Chen Y; Garry DJ; Yang HT; Rajasekaran NS
  • Start Page

  • 161
  • End Page

  • 169
  • Volume

  • 124
  • Issue

  • 1